Saturday, November 14, 2020 10:32:10 PM
Firstly, KW tweeted that she would "sell the company and retire" once it hit 4 million units sold in one year. so the rest of the exercise is moot.
Secondly, the $7 profit per unit is a huge stretch and therefore not reasonable when selling through an OEM, and especially not when selling through a licensing agreement. If there is a market for 25 million users, how many units will be purchased in each channel: retail by BioElectronics website, OEM, licensing agreement. Each has its own net revenue figure and I doubt the $7 on average stated in the hypothesis. Look at the most recent financial statement: $33k sold and COGS at $10K. That leads me to believe that the gross revenue per unit sold is around $7. Therefore, a net of $7 per unit is impossible. Don't forget about all the other operating expenses.
Thirdly, the number of shares used in the linked message is 25 billion. It should be fully diluted and be reflected by nearly 70 billion shares. FACT: When BIEL is sold, the buyer will take into account the 40+ billion shares available to those holding convertible promissory notes.
Fourthly, when the business matures in sales, like 50 million actipathces sold in a yar, its PE ratio would most likely be at a more lower number than the 100 multiple being promoted.
I couldn't go on about the fallacy of the figures presented in the linked post, but these should be sufficient to prove that the proposed valuation figures are false.
All of my comments are based on my own due diligence and are only my opinion. Please conduct your own due diligence and research before deciding whether to buy or sell any stock. My posts are for entertainment only.
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM